Fibrinolytic defect in chronic back pain: A controlled study of plasminogen activator activity in 20 patients

• Published in: Acta orthopaedica Vol. 62; no. 5; pp. 407 - 409
• Main Authors: Hurri, Heikki O., Petäjä, Jari M., Alaranta, Hannu T., Landtman, Magnus C., Soini, Juhani R., Vahtera, Elina M., Laitinen, Heikki I.
• Format: Journal Article
• Language: English
• Published: England Informa UK Ltd 1991
• Subjects: Adult; Back Pain - blood; Back Pain - etiology; Chronic Disease; Female; Fibrinolysis; Humans; Male; Middle Aged; Plasminogen Inactivators - analysis; Plethysmography; Spinal Stenosis - complications; Tissue Plasminogen Activator - analysis
• ISSN: 1745-3674; 0001-6470; 1745-3682
• DOI: 10.3109/17453679108996633

We analyzed the fibrinolytic system in patients with chronic low back pain using a venous occlusion test to stimulate fibrinolysis, and we subsequently determined the levels of tissue plasminogen activator (TPA) and fast-acting inhibitor of TPA (PAI). There were 20 patients with a mean age of 50 years. Two thirds had radiographically spinal stenosis. Scar tissue around the spinal nerves was seen in 11 cases. Thirteen patients had undergone back surgery, whereas 21 healthy subjects served as controls. in the basal samples, TPA activity was decreased in the patients while TPA antigen level was increased cornpared with the controls. No clear explanation for this defective function of TPA in the patients was obtained, because no difference was seen in PAI level in basal samples. After the venous occlusion, no difference was observed in TPA activity between the two groups excluding the constitutionally defective fibrinolytic system in the patients. However, our results confirm low basal fibrinolytic activity in patients with chronic low back pain with manifest spinal pathology.